Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy

To determine if short echo time (TE) 1H magnetic resonance spectroscopy (MRS) can distinguish between intracranial metastases and glioblastomas.

[1]  V. L. Doyle,et al.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.

[2]  Glyn Johnson,et al.  High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. , 2002, Radiology.

[3]  C Gössl,et al.  Improved analysis of 1H‐MR spectra in the presence of mobile lipids , 2001, Magnetic resonance in medicine.

[4]  Makoto Ochi,et al.  Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy , 2001, European Radiology.

[5]  G J Barker,et al.  Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter , 2000, Magnetic resonance in medicine.

[6]  Leo L. Cheng,et al.  Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. , 2000, Neuro-oncology.

[7]  Risto A. Kauppinen,et al.  1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis , 1999, Nature Medicine.

[8]  A. Stringaro,et al.  Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts. , 1999, Biochimica et biophysica acta.

[9]  I Barba,et al.  The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. , 1999, Cancer research.

[10]  B. Rosen,et al.  Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.

[11]  A R Tate,et al.  Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.

[12]  D. Arnold,et al.  Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors , 1998, NMR in biomedicine.

[13]  R. Gonzalez,et al.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A Moreno,et al.  Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. , 1997, Cancer research.

[15]  M Ala-Korpela,et al.  Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. , 1996, Neuroreport.

[16]  F Lazeyras,et al.  Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. , 1996, AJR. American journal of roentgenology.

[17]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[18]  H. Poptani,et al.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. , 1995, AJNR. American journal of neuroradiology.

[19]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[20]  M. Bernstein,et al.  Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. , 1994, Journal of neurosurgery.

[21]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[22]  P G Webb,et al.  Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.

[23]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[24]  R. Deslauriers,et al.  1H magnetic resonance of human tumours. Analysis of the transverse relaxation of the methylene protons using continuous distributions of relaxation times , 1989, NMR in biomedicine.

[25]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[26]  F. Jensen,et al.  Differences in Blood-Tumour-Barrier Leakage of Human Intracranial Tumours: Quantitative Monitoring of Vasogenic Oedema and its Response to Glucocorticoid Treatment , 1998, Acta Neurochirurgica.